Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients

Megumi Yanokura, Kouji Banno, Nobuyuki Susumu, Makiko Kawaguchi, Yoshiko Kuwabara, Kastumi Tsukazaki, Daisuke Aoki

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: p16 has been reported to disappear by hypermethylation in various cancers. However, the relationship between the frequency of hypermethylation of p16 and the mechanism of its inactivation has not been completely elucidated in endometrial cancer. Materials and Methods: Hypermethylation in the promoter region of the p16 gene and the expression of the p16 protein in 51 specimens, including 8 endometrial cancer cell lines, 7 normal endometrial tissues, 12 atypical endometrial hyperplasia tissues and 32 endometrial cancer tissues were analyzed. Results: Five out of 8 endometrial cancer cell lines showed hypermethylation with high frequency, although only 1 showed loss of gene expression. However, no endometrial cancer tissue of the 32 specimens showed hypermethylation. Furthermore, loss of expression was immunohistochemically observed in 3 out of the 20 specimens. Conclusion: These results suggest that hypermethylation of p16 rarely occurs and, thus, has no significant effect on the carcinogenesis of endometrial cancer in Japanese patients.

Original languageEnglish
Pages (from-to)851-856
Number of pages6
JournalAnticancer Research
Volume26
Issue number2 A
Publication statusPublished - 2006 Mar

Fingerprint

Endometrial Neoplasms
Genetic Promoter Regions
Carcinogenesis
p16 Genes
Endometrial Hyperplasia
Gene Expression
Cell Line
Neoplasms
Proteins

Keywords

  • Endometrial cancer
  • Hypermethylation
  • p16

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients. / Yanokura, Megumi; Banno, Kouji; Susumu, Nobuyuki; Kawaguchi, Makiko; Kuwabara, Yoshiko; Tsukazaki, Kastumi; Aoki, Daisuke.

In: Anticancer Research, Vol. 26, No. 2 A, 03.2006, p. 851-856.

Research output: Contribution to journalArticle

Yanokura, M, Banno, K, Susumu, N, Kawaguchi, M, Kuwabara, Y, Tsukazaki, K & Aoki, D 2006, 'Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients', Anticancer Research, vol. 26, no. 2 A, pp. 851-856.
Yanokura M, Banno K, Susumu N, Kawaguchi M, Kuwabara Y, Tsukazaki K et al. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients. Anticancer Research. 2006 Mar;26(2 A):851-856.
Yanokura, Megumi ; Banno, Kouji ; Susumu, Nobuyuki ; Kawaguchi, Makiko ; Kuwabara, Yoshiko ; Tsukazaki, Kastumi ; Aoki, Daisuke. / Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients. In: Anticancer Research. 2006 ; Vol. 26, No. 2 A. pp. 851-856.
@article{cb4b67c3129c4789b2045dc83ddfbb82,
title = "Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients",
abstract = "Background: p16 has been reported to disappear by hypermethylation in various cancers. However, the relationship between the frequency of hypermethylation of p16 and the mechanism of its inactivation has not been completely elucidated in endometrial cancer. Materials and Methods: Hypermethylation in the promoter region of the p16 gene and the expression of the p16 protein in 51 specimens, including 8 endometrial cancer cell lines, 7 normal endometrial tissues, 12 atypical endometrial hyperplasia tissues and 32 endometrial cancer tissues were analyzed. Results: Five out of 8 endometrial cancer cell lines showed hypermethylation with high frequency, although only 1 showed loss of gene expression. However, no endometrial cancer tissue of the 32 specimens showed hypermethylation. Furthermore, loss of expression was immunohistochemically observed in 3 out of the 20 specimens. Conclusion: These results suggest that hypermethylation of p16 rarely occurs and, thus, has no significant effect on the carcinogenesis of endometrial cancer in Japanese patients.",
keywords = "Endometrial cancer, Hypermethylation, p16",
author = "Megumi Yanokura and Kouji Banno and Nobuyuki Susumu and Makiko Kawaguchi and Yoshiko Kuwabara and Kastumi Tsukazaki and Daisuke Aoki",
year = "2006",
month = "3",
language = "English",
volume = "26",
pages = "851--856",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "2 A",

}

TY - JOUR

T1 - Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients

AU - Yanokura, Megumi

AU - Banno, Kouji

AU - Susumu, Nobuyuki

AU - Kawaguchi, Makiko

AU - Kuwabara, Yoshiko

AU - Tsukazaki, Kastumi

AU - Aoki, Daisuke

PY - 2006/3

Y1 - 2006/3

N2 - Background: p16 has been reported to disappear by hypermethylation in various cancers. However, the relationship between the frequency of hypermethylation of p16 and the mechanism of its inactivation has not been completely elucidated in endometrial cancer. Materials and Methods: Hypermethylation in the promoter region of the p16 gene and the expression of the p16 protein in 51 specimens, including 8 endometrial cancer cell lines, 7 normal endometrial tissues, 12 atypical endometrial hyperplasia tissues and 32 endometrial cancer tissues were analyzed. Results: Five out of 8 endometrial cancer cell lines showed hypermethylation with high frequency, although only 1 showed loss of gene expression. However, no endometrial cancer tissue of the 32 specimens showed hypermethylation. Furthermore, loss of expression was immunohistochemically observed in 3 out of the 20 specimens. Conclusion: These results suggest that hypermethylation of p16 rarely occurs and, thus, has no significant effect on the carcinogenesis of endometrial cancer in Japanese patients.

AB - Background: p16 has been reported to disappear by hypermethylation in various cancers. However, the relationship between the frequency of hypermethylation of p16 and the mechanism of its inactivation has not been completely elucidated in endometrial cancer. Materials and Methods: Hypermethylation in the promoter region of the p16 gene and the expression of the p16 protein in 51 specimens, including 8 endometrial cancer cell lines, 7 normal endometrial tissues, 12 atypical endometrial hyperplasia tissues and 32 endometrial cancer tissues were analyzed. Results: Five out of 8 endometrial cancer cell lines showed hypermethylation with high frequency, although only 1 showed loss of gene expression. However, no endometrial cancer tissue of the 32 specimens showed hypermethylation. Furthermore, loss of expression was immunohistochemically observed in 3 out of the 20 specimens. Conclusion: These results suggest that hypermethylation of p16 rarely occurs and, thus, has no significant effect on the carcinogenesis of endometrial cancer in Japanese patients.

KW - Endometrial cancer

KW - Hypermethylation

KW - p16

UR - http://www.scopus.com/inward/record.url?scp=33645837682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645837682&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 851

EP - 856

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 2 A

ER -